Shareholders Approve Reverse Stock Split Authority, Dilutive Stock Plan, and Warrant Issuances

summarizeSummary

Avalon GloboCare shareholders approved a reverse stock split authority to address Nasdaq delisting, alongside a new dilutive stock incentive plan and warrant issuances for a prior private placement.

check_boxKey Events

• Reverse Stock Split Authority Approved

  Stockholders approved a proposal granting the Board discretion to effect a reverse stock split at a ratio between 1-for-2 and 1-for-25. This is a critical step to regain Nasdaq compliance following a delisting notice.

• 2026 Stock Incentive Plan Approved

  Shareholders approved the Avalon GloboCare Corp. 2026 Stock Incentive Plan, which was previously identified as highly dilutive, allowing for future equity awards.

• Warrant Issuances for Prior Private Placement Approved

  Stockholders approved the issuance of Series A-1, Series A-2, and Placement Agent Warrants, totaling 13,063,728 shares, related to a private placement that closed on February 27, 2026. This approval ensures compliance with Nasdaq listing rules for the prior dilutive financing.

• Director Elections and Auditor Ratification

  Four members were elected to the Board of Directors, and M&K CPAS, PLLC was ratified as the independent registered public accounting firm for fiscal year 2026.

auto_awesomeAnalysis

Shareholders have approved several critical proposals, most notably granting the Board authority to implement a reverse stock split (1-for-2 to 1-for-25). This is a crucial step for Avalon GloboCare to regain compliance with Nasdaq's minimum bid price requirement and avoid delisting, a significant risk highlighted in previous filings. Additionally, the approval of the 2026 Stock Incentive Plan and the issuance of warrants (totaling over 13 million shares) related to a February 2026 private placement enable substantial future and past dilution, respectively. These actions underscore the company's ongoing efforts to address its precarious financial position and maintain its listing, but at the cost of significant potential dilution for existing shareholders.